CRSP · CRISPR Therapeutics AG
$59.49
+1.37 (+2.35%)
At close · Aug 21
Market Cap
$5.62B
Shares
96.69M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-10 | — | $600,000,000 | $557,200,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-03 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2018-12-31 | $57,000 | 10-K, filed 2021-02-16 |
Key facts
CIK
1674416
CUSIP
H17182108
13F (30d)
456 filings
448 filers
Visit website
Investor relations